Medtech Industry Says Latest EU AI Act Revisions Insufficient As Questions Remain
Executive Summary
Recent revisions to the European Commission’s proposed AI Act have failed to resolve uncertainties around its interaction with medtech regulations, leaving crucial parts of the legislation open to interpretation. Industry representatives have said further steps must be taken.
You may also be interested in...
Beyond MDR: How Stricter EU Rules On AI And Data Are Set To Impact Medtech
The second half of 2022 has seen much debate and concern from EU medtech stakeholders around numerous proposed horizontal rules that will affect digital products. Changes in policies around AI, cybersecurity and data-sharing are likely to be an even bigger theme in 2023.
Industry Welcomes Changes To EU AI Act, But Fears Of Overlap Remain
While recently proposed amendments to the draft EU legislation on Artificial Intelligence are a step in the right direction for medical devices, trade associations MedTech Europe and COCIR warn that the potential for regulatory conflicts remains.
Medtech Connect Episode 2: What Is The European Health Data Space?
In this episode of new podcast series Medtech Connect, Medtech Insight’s regulatory writer for Europe, Eliza Slawther, interviews Alexander Olbrechts, director for digital health at the European trade body MedTech Europe, to find out more about the proposed European Health Data Space initiative and what it means for the medical device industry.